Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections treatment news

Show

From To
The recent trend towards multi-resistant gonorrhoea in coastal China

Alarming data have recent been reported (Yin & Chen) (Y&C) from the China Gonococcal Resistance Surveillance Programme (China-GRSP), covering seven (mostly coastal) provinces in the period 2013-2016. The study is relevant for Chinese national treatment policy, which currently recommends azithromycin monotherapy. However, with an estimated 45% of the world’s 78 million incident cases occurring in [...]Read More...

Published
29 March 2018
From
BMJ Group blogs
Gonorrhoea strains across Europe becoming more susceptible to main treatment options

According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010. However, resistance to one antibiotic agent which is part of the suggested dual therapy of gonorrhoea remains high and threatens the effectiveness of this regimen.

Published
29 August 2017
From
ECDC
Sign-on Letter in Response to Critical Shortage of Penicillin for Syphilis Treatment in U.S.

Sign-on letter to Pfizer urging an immediate response to the nationwide shortage of penicillin G benzathine, the standard treatment for primary and secondary syphilis.

Published
10 July 2017
From
Treatment Action Group
Drug-resistant gonorrhoea rates plummet in US

Preliminary results announced at the US 2014 STD Prevention Conference in Atlanta have shown that the proportion of cases of gonorrhoea that are drug-resistant has fallen since 2011,

Published
16 June 2014
By
Gus Cairns
HIV infection doesn't generally affect the response to syphilis treatment

Well-controlled HIV infection does not have a significant impact on the serological response to treatment for syphilis, Swiss investigators report in the online edition of Clinical Infectious

Published
18 September 2012
By
Michael Carter
Reduced susceptibility to first-line drug causes change in UK gonorrhoea prescribing practice

UK Prescribing guidance for the treatment of gonorrhoea needs to change because of increasing prevalence of bacteria with reduced susceptibility to the first-line antibiotic cefixime, the Health

Published
11 October 2011
By
Michael Carter
Herpes drugs and viral load: valaciclovir works better than aciclovir

The anti-herpes drug valaciclovir (Valtrex, valacyclovir in the US) produced a 17-fold (1.23 log) reduction in HIV viral load in Kenyan patients not taking treatment, the sixth

Published
26 July 2011
By
Gus Cairns
Daily aciclovir slows HIV disease progression and reduces viral load

Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the

Published
19 July 2011
By
Michael Carter
Guidelines for treatment of syphilis in patients with HIV have very poor evidence base

Current guidelines for the treatment of syphilis in patients with HIV are based on limited clinical data, investigators show in the online edition of Sexually Transmitted Infections. Even

Published
21 October 2010
By
Michael Carter
One in ten people in UK with gonorrhoea have a strain with reduced susceptibility to treatment

Depending of the definition of ‘resistance’ used, between 1% and 10% of people with gonorrhoea in the UK have a strain which is resistant to the antibiotic

Published
25 August 2010
By
Roger Pebody

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.